Elicio Therapeutics, Inc. (Nasdaq: ELTX), a clinical-stage biotechnology company, was added to the Russell 2000® and Russell 3000® indexes, effective ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE